Moyamoya disease is a rare cerebrovascular disease. Is there any specific medicine to treat it?

Recently, a patient came to the outpatient clinic. The patient is a 45-year-old male. He has a son and recently started dating a girlfriend. The other party requires buying a house before getting married. Thinking about the situation at home, the patient has a headache. Two months ago, the patient was in a bad mood and smoked at home. After smoking a few cigarettes, the corner of his mouth suddenly became crooked and he fell to the ground. After being sent to the hospital, it was found that he had cerebral hemorrhage. After further examination, it was found that the patient had moyamoya disease. The local doctor recommended that the patient undergo surgery. The patient refused, so he came to Beijing for treatment and asked if there was any specific medicine for the treatment of moyamoya disease.

The main impact of moyamoya disease on people is cerebral stroke. For some reason, the large blood vessels in the brain of patients with moyamoya disease are blocked, and small compensatory blood vessels are formed around them. If the growth rate of the patient's compensatory blood vessels is faster than the occlusion rate of the large blood vessels, the patient's brain blood supply is sufficient and no abnormalities will occur. On the contrary, the patient's brain blood supply is insufficient, the brain is ischemic and hypoxic, and transient cerebral ischemia and cerebral infarction are prone to occur.

The compensatory blood vessels formed around the brain are fragile and prone to rupture. When blood pressure rises, blood vessels cannot withstand the pressure and are prone to bleeding. Some patients are affected by vascular dynamics and have aneurysms. Rupture of aneurysms can also easily cause cerebral hemorrhage.

There is currently no specific drug for moyamoya disease. Drugs such as aspirin and Plavix can only temporarily relieve the symptoms of patients with moyamoya disease, but cannot reduce the risk of stroke in patients. Some patients take drugs for a long time and still suffer from stroke in the end, thinking that long-term medication has caused drug resistance. In fact, the patient's moyamoya disease has been developing and has not been effectively controlled. This is because drugs can neither prevent the patient's vascular occlusion nor prevent compensatory vascular rupture. For patients with moyamoya disease, surgical treatment is recommended.

There are three types of surgical treatment: direct revascularization, indirect revascularization and combined vascular bypass surgery. There is no difference between these three surgical methods. The specific surgical method to be used should be determined according to the patient's condition. After surgical treatment, the patient's brain blood supply is improved, reducing the risk of stroke.